Food & Beverages Global On demand · 24-48h

Global Nutritional Gummy Manufacturing (OEM/ODM) Market Strategic Research Report

Global Nutritional Gummy Manufacturing (OEM/ODM) Market Stra…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Nutritional Gummy Manufacturing (OEM/ODM) Market
$7.4B2025
11.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: OEM Manufacturing, ODM Manufacturing, Contract Manufacturing, Private Label Manufacturing, Full-Service CDMO

By Application: E-Commerce, Pharmacy, Supermarket, Health Food Store Gummies, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Sirio Pharma, IVC Nutrition, Weihai Baihe Biology, Guangdong Yichao Biological, Catalent Consumer Health, SCN BestCo, Makers Nutrition, Gummi World, SMP Nutra, GMP Laboratories, Intermountain Nutrition, Herbaland Naturals, Sofgen Pharma, Funtrition, Aenova, Amapharm, Activ’Inside, Nakanihon Capsule

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 122 pages
Market size 2025
$7.4B
Billion USD
Forecast CAGR
11.8%
2025-2032
Forecast 2032
$16.2B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Nutritional Gummy Manufacturing (OEM/ODM) market size is predicted to grow from US$ 7,396 million in 2025 to US$ 16,054 million in 2032; it is expected to grow at a CAGR of 11.8% from 2026 to 2032.

Nutritional gummy contract manufacturing refers to the provision of comprehensive services—including formula development, production, filling, packaging, and regulatory compliance—by manufacturing firms on behalf of brand owners for functional gummies containing ingredients such as vitamins, minerals, probiotics, and collagen. This product category is characterized by its pleasant taste, modern dosage form, ease of consumption, and high level of consumer acceptance.

The upstream supply chain primarily comprises raw materials such as gelatin, pectin, sugar alcohols, sweeteners, flavorings and colorants, vitamins, minerals, plant extracts, probiotics, collagen, and packaging materials. The downstream market targets health supplement brands, pharmacy channels, e-commerce platforms, maternal and infant care brands, beauty and nutrition brands, and cross-border nutritional product enterprises.

The global nutritional gummy contract manufacturing market is projected to be driven in the future by the upgrading of functional nutrition consumption, growing demand for children's and women's health products, the rising popularity of sugar-free and low-sugar formulations, and the adoption of asset-light operational models by brands. Compared to tablets, capsules, and powders, gummies align more closely with consumer trends favoring snack-like formats, portability, and high adherence rates; they are particularly well-suited for applications such as multivitamins, immune support, beauty nutrition, sleep management, and gut health. Moving forward, contract manufacturers will place greater emphasis on formula stability, the preservation of active ingredients, low-sugar and plant-based formulations, flavor innovation, and regulatory compliance capabilities. Concurrently, the expansion of cross-border e-commerce, Direct-to-Consumer (DTC) brands, and private-label products will drive the nutritional gummy contract manufacturing sector toward upgrades in flexible manufacturing, rapid prototyping, and comprehensive one-stop ODM services.

This report presents a comprehensive overview of the global Nutritional Gummy Manufacturing (OEM/ODM) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • OEM Manufacturing
  • ODM Manufacturing
  • Contract Manufacturing
  • Private Label Manufacturing
  • Full-Service CDMO

Segment by Dosage Form

  • Pectin Gummies
  • Gelatin Gummies
  • Starch-Based Gummies
  • Sugar-Free Gummies
  • Low-Sugar Gummies
  • Vegan Gummies
  • Chewable Functional Gummies

Segment by Application

  • E-Commerce
  • Pharmacy
  • Supermarket
  • Health Food Store Gummies
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Nutritional Gummy Manufacturing (OEM/ODM) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in E-Commerce, Pharmacy, Supermarket evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Nutritional Gummy Manufacturing (OEM/ODM) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 11.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$7.4B
2025
Forecast
$16.2B
2032
CAGR
11.8%
2025–2032
Regiões
5
global
Key companies
Sirio PharmaIVC NutritionWeihai Baihe BiologyGuangdong Yichao BiologicalCatalent Consumer HealthSCN BestCoMakers NutritionGummi World
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
OEM ManufacturingODM ManufacturingContract ManufacturingPrivate Label ManufacturingFull-Service CDMO
By Application
E-CommercePharmacySupermarketHealth Food Store GummiesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 OEM Manufacturing
  • 3.1.3 ODM Manufacturing
  • 3.1.4 Contract Manufacturing
  • 3.1.5 Private Label Manufacturing
  • 3.1.6 Full-Service CDMO
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 E-Commerce
  • 4.1.3 Pharmacy
  • 4.1.4 Supermarket
  • 4.1.5 Health Food Store Gummies
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Sirio Pharma
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 IVC Nutrition
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Weihai Baihe Biology
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Guangdong Yichao Biological
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Catalent Consumer Health
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 SCN BestCo
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Makers Nutrition
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Gummi World
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 SMP Nutra
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 GMP Laboratories
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Intermountain Nutrition
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Herbaland Naturals
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Sofgen Pharma
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Funtrition
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Aenova
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Amapharm
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Activ’Inside
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Nakanihon Capsule
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Nutritional Gummy Manufacturing (OEM/ODM) market size?
The global Nutritional Gummy Manufacturing (OEM/ODM) market is estimated at US$ 7.4 billion in 2025 (base year) and is projected to reach US$ 16.05 billion by 2032.
What growth rate is expected for the Nutritional Gummy Manufacturing (OEM/ODM) market through 2032?
The market is expected to grow at a CAGR of 11.8% from 2026 to 2032, expanding from US$ 7.4 billion in 2025 to US$ 16.05 billion in 2032, roughly 2.2 times its base-year value.
How is Nutritional Gummy Manufacturing (OEM/ODM) defined?
Nutritional gummy contract manufacturing refers to the provision of comprehensive services—including formula development, production, filling, packaging, and regulatory compliance—by manufacturing firms on behalf of brand owners for functional gummies containing ingredients such as vitamins, minerals, probiotics, and collagen. This product category is characterized by its pleasant taste, modern dosage form, ease of consumption, and high level of consumer acceptance.
What are the main segments of the Nutritional Gummy Manufacturing (OEM/ODM) market by type?
By type, the market is segmented into OEM Manufacturing, ODM Manufacturing, Contract Manufacturing, Private Label Manufacturing and Full-Service CDMO.
Which applications drive demand in the Nutritional Gummy Manufacturing (OEM/ODM) market?
Key applications covered include E-Commerce, Pharmacy, Supermarket, Health Food Store Gummies and Others.
Who are the key players in the Nutritional Gummy Manufacturing (OEM/ODM) market?
Key players profiled include Sirio Pharma, IVC Nutrition, Weihai Baihe Biology, Guangdong Yichao Biological, Catalent Consumer Health, SCN BestCo, Makers Nutrition and Gummi World, among 18 companies covered in total.
Which regions and countries are covered for Nutritional Gummy Manufacturing (OEM/ODM)?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Nutritional Gummy Manufacturing (OEM/ODM) market?
The global nutritional gummy contract manufacturing market is projected to be driven in the future by the upgrading of functional nutrition consumption, growing demand for children's and women's health products, the rising popularity of sugar-free and low-sugar formulations, and the adoption of asset-light operational models by brands.
Who should buy the Nutritional Gummy Manufacturing (OEM/ODM) market report?
The report is intended for manufacturers and solution providers, distributors and end users in E-Commerce, Pharmacy and Supermarket, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Nutritional Gummy Manufacturing (OEM/ODM) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.